US BANCORP \DE\ - PEAR THERAPEUTICS INC ownership

PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 54 filers reported holding PEAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PEAR THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$13,999
-78.4%
54,8970.0%0.00%
Q4 2022$64,778
-42.2%
54,8970.0%0.00%
Q3 2022$112,00054,8970.00%
Other shareholders
PEAR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Arboretum Ventures, LLC 10,859,050$2,769,0588.16%
Palantir Technologies Inc. 700,000$178,5001.14%
5AM Venture Management, LLC 16,744,113$4,269,7491.09%
TB Alternative Assets Ltd. 2,071,865$528,3260.13%
EDBI Pte Ltd 427,070$108,9030.12%
Temasek Holdings (Private) Ltd 26,803,573$6,834,9110.04%
SoftBank Group 12,100,078$3,085,5200.04%
Sarissa Capital Management LP 500,356$127,5910.02%
Perceptive Advisors 900,548$229,6390.01%
Legal & General Group Plc 7,198$1,8360.00%
View complete list of PEAR THERAPEUTICS INC shareholders